FDA Approved: REVATIO — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for REVATIO (sildenafil citrate) submitted by Viatris Specialty LLC, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• REVATIO (SILDENAFIL CITRATE)

Snippet

SUPPL AP for REVATIO (SILDENAFIL CITRATE)